|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zeng H, Zheng R, Zhang S, Zuo T, Xia C,
Zou X and Chen W: Esophageal cancer statistics in China, 2011:
Estimates based on 177 cancer registries. Thoracic cancer.
7:232–237. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rustgi A and El-Serag H: Esophageal
carcinoma. N Engl J Med. 372:1472–1473. 2015.PubMed/NCBI
|
|
5
|
Shimada H, Nabeya Y, Okazumi SI, Matsubara
H, Miyazawa Y, Shiratori T, Hayashi H, Gunji Y and Ochiai T:
Prognostic significance of CYFRA 21-1 in patients with esophageal
squamous cell carcinoma. J Am Coll Surg. 196:573–578. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shimada H, Nabeya Y, Okazumi SI, Matsubara
H, Shiratori T, Gunji Y, Kobayashi S, Hayashi H and Ochiai T:
Prediction of survival with squamous cell carcinoma antigen in
patients with resectable esophageal squamous cell carcinoma.
Surgery. 133:486–494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Park HI, Ni J, Gerkema FE, Liu D,
Belozerov VE and Sang QX: Identification and characterization of
human endometase (matrix metalloproteinase-26) from endometrial
tumor. J Biol Chem. 275:20540–20544. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Page-McCaw A, Ewald AJ and Werb Z: Matrix
metalloproteinases and the regulation of tissue remodelling. Nat
Rev Mol Cell Biol. 8:221–233. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang S, Jia J, Liu D, Wang M, Wang Z, Li
X, Wang H, Rui Y, Liu Z, Guo W, et al: Matrix Metalloproteinase
expressions play important role in prediction of ovarian cancer
outcome. Sci Rep. 9:116772019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gobin E, Bagwell K, Wagner J, Mysona D,
Sandirasegarane S, Smith N, Bai S, Sharma A, Schleifer R and She
JX: A pan-cancer perspective of matrix metalloproteases (MMP) gene
expression profile and their diagnostic/prognostic potential. BMC
cancer. 19:5812019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng HH, Zhang X and Cao PG: MMP-1/PAR-1
signal transduction axis and its prognostic impact in esophageal
squamous cell carcinoma. Braz J Med Biol Res. 45:86–92. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Han F, Zhang S, Zhang L and Hao Q: The
overexpression and predictive significance of MMP-12 in esophageal
squamous cell carcinoma. Pathol Res Pract. 213:1519–1522. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang X, Zhu S, Li L, Zhang L, Xian S, Wang
Y and Cheng Y: Identification of differentially expressed genes and
signaling pathways in ovarian cancer by integrated bioinformatics
analysis. Onco Targets Ther. 11:1457–1474. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zheng MJ, Li X, Hu YX, Dong H, Gou R, Nie
X, Liu Q, Ying-Ying H, Liu JJ and Lin B: Identification of
molecular marker associated with ovarian cancer prognosis using
bioinformatics analysis and experiments. J Cell Physiol.
234:11023–11036. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Chen Z, Tian L, Zhou C, He MY, Gao
Y, Wang S, Zhou F, Shi S, Feng X, et al: LncRNA profile study
reveals a three-lncRNA signature associated with the survival of
patients with oesophageal squamous cell carcinoma. Gut.
63:1700–1710. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su H, Hu N, Yang HH, Wang C, Takikita M,
Wang QH, Giffen C, Clifford R, Hewitt SM, Shou JZ, et al: Global
gene expression profiling and validation in esophageal squamous
cell carcinoma and its association with clinical phenotypes. Clin
Cancer Res. 17:2955–2966. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu N, Wang C, Clifford RJ, Yang HH, Su H,
Wang L, Wang Y, Xu Y, Tang ZZ, Ding T, et al: Integrative genomics
analysis of genes with biallelic loss and its relation to the
expression of mRNA and micro-RNA in esophageal squamous cell
carcinoma. BMC Genomics. 16:7322015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brierley JD, Gospodarowicz MK and
Wittekind C: TNM classification of malignant tumours, 8th edition.
John Wiley & Sons; 2017
|
|
20
|
Team RC: A language and environment for
statistical computing. R Foundation for Statistical Computing.
(Vienna, Austria). ISBN 3-900051-07-0. Journal 2012, .
|
|
21
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth G: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: A Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cox DR: Regression models and life-tables.
J Royal Stat Soc Series B (Methodological). 34:187–202. 1972.
View Article : Google Scholar
|
|
24
|
Iasonos A, Schrag D, Raj GV and Panageas
KS: How to build and interpret a nomogram for cancer prognosis. J
Clin Oncol. 26:1364–1370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lüdemann L, Grieger W, Wurm R, Wust P and
Zimmer C: Glioma assessment using quantitative blood volume maps
generated by T1-weighted dynamic contrast-enhanced magnetic
resonance imaging: A receiver operating characteristic study. Acta
Radiol. 47:303–310. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harrell FE Jr: rms: Regression modeling
strategies. R package version 5.1-2. http://cran.nexr.com/web/packages/rms/rms.pdfJanuary
7–2018
|
|
27
|
Subramanian A, Tamayo P, Mootha VK,
Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub
TR, Lander ES and Mesirov JP: Gene set enrichment analysis: A
knowledge-based approach for interpreting genome-wide expression
profiles. Proc Natl Acad Sci USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liberzon A: A description of the molecular
signatures database (MSigDB) web site. Stem Cell Transcriptional
Networks. Springer. 153–160. 2014. View Article : Google Scholar
|
|
29
|
Langfelder P and Horvath S: WGCNA: An R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
D'Journo XB: Clinical implication of the
innovations of the 8th edition of the TNM classification for
esophageal and esophago-gastric cancer. J Thorac Dis. 10 (Suppl
22):S2671–S2681. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang Q, Wang F, Lv J, Xin J, Xie L, Zhu W,
Tang Y, Li Y, Zhao X, Wang Y, et al: Interactive online consensus
survival tool for esophageal squamous cell carcinoma prognosis
analysis. Oncol Lett. 18:1199–1206. 2019.PubMed/NCBI
|
|
33
|
Lambert R and Hainaut P: Epidemiology of
oesophagogastric cancer. Best Pract Res Clin Gastroenterol.
21:921–945. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Coussens LM, Fingleton B and Matrisian LM:
Matrix metalloproteinase inhibitors and cancer-trials and
tribulations. Science. 295:2387–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Duffy MJ, Maguire TM, Hill A, McDermott E
and O'Higgins N: Metalloproteinases: Role in breast carcinogenesis,
invasion and metastasis. Breast Cancer Res. 2:252–257. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen
J, Fu JH and Yang H: MMP1 promotes tumor growth and metastasis in
esophageal squamous cell carcinoma. Cancer Lett. 377:97–104. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Li H, Qiu Z, Li F and Wang C: The
relationship between MMP-2 and MMP-9 expression levels with breast
cancer incidence and prognosis. Oncol Lett. 14:5865–5870.
2017.PubMed/NCBI
|
|
38
|
Zeng R, Duan L, Kong Y, Liang Y, Wu X, Wei
X and Yang K: Clinicopathological and prognostic role of MMP-9 in
esophageal squamous cell carcinoma: A meta-analysis. Chin J Cancer
Res. 25:6372013.PubMed/NCBI
|
|
39
|
Gu ZD, Li JY, Li M, Gu J, Shi XT, Ke Y and
Chen KN: Matrix metalloproteinases expression correlates with
survival in patients with esophageal squamous cell carcinoma. Am J
Gastroenterol. 100:1835–1843. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mroczko B, Kozłowski M, Groblewska M,
Łukaszewicz M, Nikliński J, Jelski W, Laudański J, Chyczewski L and
Szmitkowski M: The diagnostic value of the measurement of matrix
metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and
carcinoembryonic antigen (CEA) in the sera of esophageal cancer
patients. Clin Chim Acta. 389:61–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Ma J, Guo Q, Duan F, Tang F, Zheng
P, Zhao Z and Lu G: Overexpression of MMP-2 and MMP-9 in esophageal
squamous cell carcinoma. Dis Esophagus. 22:664–667. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chai R, Zhang K, Wang K, Li G, Huang R,
Zhao Z, Liu Y and Chen J: A novel gene signature based on five
glioblastoma stem-like cell relevant genes predicts the survival of
primary glioblastoma. J Cancer Res Clin Oncol. 144:439–447. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu GM, Xie WX, Zhang CY and Xu JW:
Identification of a four-gene metabolic signature predicting
overall survival for hepatocellular carcinoma. J Cell Physiol.
235:1624–1636. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mariani P, Dureau S, Savignoni A, Rouic
LL, Levy-Gabriel C, Piperno-Neumann S, Rodrigues MJ, Desjardins L,
Cassoux N and Servois V: Development of a prognostic nomogram for
liver metastasis of uveal melanoma patients selected by liver MRI.
Cancers (Basel). 11:E8632019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Orlichenko LS and Radisky DC: Matrix
metalloproteinases stimulate epithelial-mesenchymal transition
during tumor development. Clin Exp Metastasis. 25:593–600. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Moirangthem A, Bondhopadhyay B, Mukherjee
M, Bandyopadhyay A, Mukherjee N, Konar K, Bhattacharya S and Basu
A: Simultaneous knockdown of uPA and MMP9 can reduce breast cancer
progression by increasing cell-cell adhesion and modulating EMT
genes. Sci Rep. 6:219032016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pang L, Li Q, Li S, He J, Cao W, Lan J,
Sun B, Zou H, Wang C, Liu R, et al: Membrane type 1-matrix
metalloproteinase induces epithelial-to-mesenchymal transition in
esophageal squamous cell carcinoma: Observations from clinical and
in vitro analyses. Sci Rep. 6:221792016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Osako Y, Seki N, Kita Y, Yonemori K,
Koshizuka K, Kurozumi A, Omoto I, Sasaki K, Uchikado Y, Kurahara H,
et al: Regulation of MMP13 by antitumor microRNA-375 markedly
inhibits cancer cell migration and invasion in esophageal squamous
cell carcinoma. Int J Oncol. 49:2255–2264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Bai X, Li YY, Zhang HY, Wang F, He HL, Yao
JC, Liu L and Li SS: Role of matrix metalloproteinase-9 in
transforming growth factor-β1-induced epithelial-mesenchymal
transition in esophageal squamous cell carcinoma. Onco Targets
Ther. 10:2837–2847. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Rajasinghe LD, Pindiprolu RH and Gupta SV:
Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion
via the inhibition of NF-κB, uPA activator, and MMP-9. Onco Targets
Ther. 11:4301–4314. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ganguly SS, Hostetter G, Tang L, Frank SB,
Saboda K, Mehra R, Wang L, Li X, Keller ET and Miranti CK: Notch3
promotes prostate cancer-induced bone lesion development via MMP-3.
Oncogene. 39:204–218. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Takebe N, Nguyen D and Yang SX: Targeting
notch signaling pathway in cancer: Clinical development advances
and challenges. Pharmacol Ther. 141:140–149. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ma J, Tang X, Wong P, Jacobs B, Borden EC
and Bedogni B: Noncanonical activation of Notch1 protein by
membrane type 1 matrix metalloproteinase (MT1-MMP) controls
melanoma cell proliferation. J Biol Chem. 289:8442–8449. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Chen JS, Wang Q, Fu Xh, Huang XH, Chen XL,
Cao LQ, Chen LZ, Tan HX, Li W, Bi J and Zhang LJ: Involvement of
PI3K/PTEN/AKT/mTOR pathway in invasion and metastasis in
hepatocellular carcinoma: Association with MMP-9. Hepatol Res.
39:177–186. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Powell E, Piwnica-Worms D and
Piwnica-Worms H: Contribution of p53 to metastasis. Cancer Discov.
4:405–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Mellor P, Deibert L, Calvert B, Bonham K,
Carlsen SA and Anderson DH: CREB3L1 is a metastasis suppressor that
represses expression of genes regulating metastasis, invasion, and
angiogenesis. Mol Cell Biol. 33:4985–4995. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jabłońska-Trypuć A, Matejczyk M and
Rosochacki S: Matrix metalloproteinases (MMPs), the main
extracellular matrix (ECM) enzymes in collagen degradation, as a
target for anticancer drugs. J Enzyme Inhib Med Chem. 31:177–183.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Ricard-Blum S: The collagen family. Cold
Spring Harb Perspect Biol. 3:a0049782011. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zhang H, Teng X and Liu Z, Zhang L and Liu
Z: Gene expression profile analyze the molecular mechanism of CXCR7
regulating papillary thyroid carcinoma growth and metastasis. J Exp
Clin Cancer Res. 34:162015. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kaminska B, Wesolowska A and Danilkiewicz
M: TGF beta signalling and its role in tumour pathogenesis. Acta
Biochim Pol. 52:329–337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Wang X, Fu X, Brown P, Crimmin M and
Hoffman R: Matrix metalloproteinase inhibitor BB-94 (batimastat)
inhibits human colon tumor growth and spread in a patient-like
orthotopic model in nude mice. Cancer Res. 54:4726–4728.
1994.PubMed/NCBI
|
|
62
|
Erba E, Ronzoni S, Bassano L, Giavazzi R
and D'lncalci M: The metalloproteinase inhibitor batimastat (BB-94)
causes cell cycle phase perturbations in ovarian cancer cells. Ann
Oncol. 10:589–591. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Kirkegaard T, Yde CW, Kveiborg M and
Lykkesfeldt AE: The broad-spectrum metalloproteinase inhibitor
BB-94 inhibits growth, HER3 and Erk activation in
fulvestrant-resistant breast cancer cell lines. Int J Oncol.
45:393–400. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Peng L, Bian XW, Xu C, Wang GM, Xia QY and
Xiong Q: Large-scale RNA-Seq transcriptome analysis of 4043 cancers
and 548 normal tissue controls across 12 TCGA cancer types. Sci
Rep. 5:134132015. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Ricci S, Grandgirard D, Wenzel M, Braccini
T, Salvatore P, Oggioni MR, Leib SL and Koedel U: Inhibition of
matrix metalloproteinases attenuates brain damage in experimental
meningococcal meningitis. BMC Infect Dis. 14:7262014. View Article : Google Scholar : PubMed/NCBI
|
